This month: shorter recovery after TAVI, Down syndrome CV insights, the benefits of brisker walking, and more.

Juan Granada, MD, and Brian Lindman, MD, share insights on tools and data that can be used to ahieve earlier diagnosis and ...

For all the different subpopulations, having a CAC score > 100 strongly predicted risk of CV death (P < 0.007). Yet the ...

Once-daily orforglipron was more effective than placebo and just as safe as injectable GLP-1s in patients with diabetes and ...

Numerous components beyond length of sleep have important ties to cardiometabolic disease and related risk factors.

In patients with gastrointestinal cancers treated with fluoropyrimidine-based chemotherapy agents, better overall survival at ...

The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.

There’s room on the market for new TAVI valves as long as they can compete with the best in practice, a researcher says.

The ABCVM wanted to certify cardiologists outside of ABIM, but the recent denial doesn’t mean their efforts have stopped.

Clinicians need to address maternal health at all stages, with some seeing a possible new role for GLP-1 drugs.

For every 100,000 runners who complete the full 42.2 km distance, there will be one cardiac arrest, new data show.

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...